Introduction: Gastric cancer is the fourth commonest cancer worldwide. It is also recognized as the second commonest cause of cancer related death in the global perspective. Although the incidence of gastric cancer has gradually decreased over the last half of the century, it varies among the different part of the world and different ethnic group. Mortality from gastric cancer extremely high, and it is second only to lung cancer. Gastric cancer occurs more frequently in men than in women. Aim of the study: Aim of the study was to find out expression of HER2 in gastric carcinoma. Material & Methods: This cross sectional study was conducted in the Department of Surgical Oncology of National Institute of Cancer, Research and Hospital, Mohakhal...
INTRODUCTION: Adenocarcinoma of stomach, so called “Captain of men of death” was the leading cause ...
[Background] A recent randomized controlled trial (Trastuzumab for Gastric Cancer [ToGA] study) esta...
Aim: To study the prevalence of HER-2 expression in gastric adenocarcinoma and its correlation with ...
BACKGROUND: HER2 protein expression in gastric carcinoma, in correlation with existing, acknowledged...
Background: Gastric carcinomas are the fifth most common cancer worldwide and cause the second most ...
Background: Gastric carcinoma is a deadly disease with high mortality. A better understanding of the...
Introduction: Gastric carcinoma is a substantial health-care problem worldwide, with over 6.8% of to...
Gastric carcinoma is the second common cause of cancer related worldwide deaths. The HER-2/neu is th...
Background Worldwide, gastric cancer is the fourth cancer in incidence and the second most common ca...
BACKGROUND: Gastric cancer is the one of the leading causes of cancer related death worldwide. Epid...
BACKGROUND: Carcinoma of stomach is one of the leading causes of cancer deaths in the world. Paucit...
Background Gastric cancer is a leading cause of cancer-related mortality, and current treatment outc...
Background Gastric cancer is a leading cause of cancer-related mortality, and current treatment outc...
Introduction: HER2 overexpression is present in 7 to 34% of gastric carcinomas. Several studies have...
Background/Aim: Gastric cancer is the third leading cause of cancer mortality worldwide. Human epide...
INTRODUCTION: Adenocarcinoma of stomach, so called “Captain of men of death” was the leading cause ...
[Background] A recent randomized controlled trial (Trastuzumab for Gastric Cancer [ToGA] study) esta...
Aim: To study the prevalence of HER-2 expression in gastric adenocarcinoma and its correlation with ...
BACKGROUND: HER2 protein expression in gastric carcinoma, in correlation with existing, acknowledged...
Background: Gastric carcinomas are the fifth most common cancer worldwide and cause the second most ...
Background: Gastric carcinoma is a deadly disease with high mortality. A better understanding of the...
Introduction: Gastric carcinoma is a substantial health-care problem worldwide, with over 6.8% of to...
Gastric carcinoma is the second common cause of cancer related worldwide deaths. The HER-2/neu is th...
Background Worldwide, gastric cancer is the fourth cancer in incidence and the second most common ca...
BACKGROUND: Gastric cancer is the one of the leading causes of cancer related death worldwide. Epid...
BACKGROUND: Carcinoma of stomach is one of the leading causes of cancer deaths in the world. Paucit...
Background Gastric cancer is a leading cause of cancer-related mortality, and current treatment outc...
Background Gastric cancer is a leading cause of cancer-related mortality, and current treatment outc...
Introduction: HER2 overexpression is present in 7 to 34% of gastric carcinomas. Several studies have...
Background/Aim: Gastric cancer is the third leading cause of cancer mortality worldwide. Human epide...
INTRODUCTION: Adenocarcinoma of stomach, so called “Captain of men of death” was the leading cause ...
[Background] A recent randomized controlled trial (Trastuzumab for Gastric Cancer [ToGA] study) esta...
Aim: To study the prevalence of HER-2 expression in gastric adenocarcinoma and its correlation with ...